Impact of Minimal Residual Disease Detection by Next-Generation Flow Cytometry in Multiple Myeloma Patients with Sustained Complete Remission after Frontline Therapy
暂无分享,去创建一个
M. Dimopoulos | I. Trougakos | O. Tsitsilonis | B. Paiva | E. Kastritis | M. Gavriatopoulou | E. Terpos | D. Ziogas | M. Spyropoulou-Vlachou | D. Fotiou | I. Ntanasis-Stathopoulos | N. Kanellias | M. Migkou | E. Eleutherakis-Papaiakovou | A. Argyriou | A. Papanota | Pantelis Rousakis | Ioannis V. Kostopoulos